Furthermore, the manuscript underscores the limited existing guidelines regarding the use of granulocyte colony-stimulating factor (G-CSF) in non-chemotherapy-induced neutropenia and stresses the need for more comprehensive recommendations and research on the use of G-CSF in various forms of neutropenia. This evidence concerns the gene CSF3 and Decreased total neutrophil count.